Bevin McMullin
Overview
Explore the profile of Bevin McMullin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Regev-Shoshani G, Vimalanathan S, McMullin B, Road J, Av-Gay Y, Miller C
Nitric Oxide
. 2013 Apr;
31:48-53.
PMID: 23562771
Gaseous nitric oxide (gNO) is an approved vasodilator drug for inhalation up to a maximum dose of 80 ppm. While gNO has been shown, in vitro, to be an effective...
2.
Miller C, Miller M, McMullin B, Regev G, Serghides L, Kain K, et al.
J Cyst Fibros
. 2012 Apr;
11(4):324-31.
PMID: 22520076
Background: Nitric oxide (NO) is an approved pulmonary vasodilator for neonates and full term infants up to a dose of 80 ppm. At 100 ppm to 200 ppm, NO has...
3.
Rezakhanlou A, Miller C, McMullin B, Ghaffari A, Garcia R, Ghahary A
Cell Biol Int
. 2010 Dec;
35(4):407-15.
PMID: 21155711
NO (nitric oxide) molecule is produced by various mammalian cell types and plays a significant role in inflammation, infection and wound healing processes. Recently, gNO (gaseous nitric oxide) therapy has...
4.
Miller C, McMullin B, Ghaffari A, Stenzler A, Pick N, Roscoe D, et al.
Nitric Oxide
. 2008 Sep;
20(1):16-23.
PMID: 18789393
Previously, we have shown that gaseous Nitric oxide (gNO) has great potential as an effective topical anti-infective agent for non-healing wounds due to its non-specific antimicrobial properties. These same antimicrobial...